D-0545-2024 Class II

Recalled by Winder Laboratories, LLC — Winder, GA

FDA drug recall D-0545-2024 was initiated by Winder Laboratories, LLC on May 28, 2024 and is designated Class II. Reason for recall: Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg. Affected quantity: 473 cases (5676 Bottles).

Recall details

Product Type
Drugs
Report Date
Jun 19, 2024
Initiation Date
May 28, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
473 cases (5676 Bottles)

Product description

Phenazopyridine HCl Tablets USP, 100 mg, 100-count bottles, Rx Only, Manufactured by: Winder Laboratories, LLC. 716 Patrick Industrial Lane, Winder, GA 30680, NDC 75826-114-10,

Reason for recall

Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

Distribution pattern

Nationwide within the United States

Code information

Lot#: 1142404 Exp. Date 02/27/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0545-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0545-2024. Report a data issue: hello@regdatalab.com.